REG - Indivior PLC - Notice of Results

IndiviorAnnouncement

10/04/2025 17:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250410:nRSJ5799Ea&default-theme=true

RNS Number : 5799E  Indivior PLC  10 April 2025

Indivior to Announce Q1 2025 Results and Host Webcast on April 24(th)

Slough, UK, and Richmond, VA, April 10, 2025 - Indivior PLC (NASDAQ/LSE: INDV)
today announced that it will release its Q1 2025 results on April 24(th) at
7:00 a.m. London time (2:00 a.m. U.S. Eastern). The results will be available
via the London Stock Exchange's Regulatory News Service (RNS) and on the
"Investors" section of the company's website at www.indivior.com
(http://www.indivior.com) .

Mark Crossley, Chief Executive Officer, and other members of Indivior's
leadership team will host a presentation via live webcast at 1:00 p.m. London
time (8:00 a.m. U.S. Eastern) on April 24(th).

Access to the Live Webcast Presentation:

The webcast event and materials can be accessed on the "Investors" section of
the company's website at www.indivior.com (http://www.indivior.com) before the
event begins.

The webcast link: Q1 2025 Webcast
(https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fedge.media-server.com%2Fmmc%2Fp%2Fyn37cxqk&data=05%7C02%7Ctimothy.owens%40Indivior.com%7Cd4aefc532bec4aa4712208dd66d60e38%7Cbed52191489442999db948e4fb29646e%7C1%7C0%7C638779792058719905%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=Nhu1bEMzeG6FhGu%2FRVpFt7I3LRezLDQqIui%2FOZ%2FOSiQ%3D&reserved=0)

 

Participants may access the presentation telephonically by registering with
the following link:

Conference Registration
(https://register-conf.media-server.com/register/BI4482694d7c294502b6a4dedd62e88c5b)

(Registrants will have an option to be called back directly immediately prior
to the call or be provided a call-in # with a unique pin code following their
registration)

A replay of the presentation will be available at www.indivior.com
(http://www.indivior.com) .

About Indivior

Indivior is a global pharmaceutical company working to help change patients'
lives by developing medicines to treat substance use disorders (SUD). Our
vision is that all patients around the world will have access to
evidence-based treatment for the chronic conditions and co-occurring disorders
of SUD. Indivior is dedicated to transforming SUD from a global human crisis
to a recognized and treated chronic disease. Building on its global portfolio
of OUD treatments, Indivior has a pipeline of product candidates designed to
expand on its heritage in this category. Headquartered in the United States in
Richmond, VA, Indivior employs over 1,000 individuals globally and its
portfolio of products is available in over 30 countries worldwide.
Visit www.indivior.com
(https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4271839-1%26h%3D3117038971%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D4245151-1%2526h%253D1246464342%2526u%253Dhttps%25253A%25252F%25252Fwww.indivior.com%25252Fen%2526a%253Dwww.indivior.com%26a%3Dwww.indivior.com&data=05%7C02%7Ctimothy.owens%40Indivior.com%7C31ce26374edf4dfbc1d408dd1edcf9af%7Cbed52191489442999db948e4fb29646e%7C1%7C0%7C638700656623483369%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=qBtFBN3PgUJr4tF%2FxBzFOXY0sja6ffl3Qq6Dmaam3hQ%3D&reserved=0)
 to learn more. Connect with Indivior on LinkedIn by
visiting www.linkedin.com/company/indivior
(https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4271839-1%26h%3D2950697406%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D4245151-1%2526h%253D27799095%2526u%253Dhttp%25253A%25252F%25252Fwww.linkedin.com%25252Fcompany%25252Findivior%2526a%253Dwww.linkedin.com%25252Fcompany%25252Findivior.%26a%3Dwww.linkedin.com%252Fcompany%252Findivior&data=05%7C02%7Ctimothy.owens%40Indivior.com%7C31ce26374edf4dfbc1d408dd1edcf9af%7Cbed52191489442999db948e4fb29646e%7C1%7C0%7C638700656623515198%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=5%2B9q%2FWDjPihKkjrPzBYLC8dCtGvdAARoDOW3y6ABGvE%3D&reserved=0)
.

 

Contact:

Jason Thompson

Vice President, Investor Relations

Tel: 804-402-7123 or jason.thompson@indivior.com
(mailto:jason.thompson@indivior.com)

 

Tim Owens

Director, Investor Relations

Tel: 804-263-3978 or timothy.owens@indivior.com
(mailto:timothy.owens@indivior.com)

###

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOREASLEFLPSEFA